FDA-NCI Workshop on Therapeutic Cancer Vaccines |
|
|---|---|
|
|
|
| Launch in standalone player | |
| Air date: | Tuesday, October 27, 2009, 8:00:00 AM Time displayed is Eastern Time, Washington DC Local |
| Category: | Conferences |
| Description: | FDA and NCI are holding a public workshop intended to facilitate the development of safe and effective cancer vaccine by optimizing early phase clinical trials based on lessons learned from completed Phase III studies.
In this workshop, the role of randomized Phase II clinical trials and adaptive study designs will be discussed. Furthermore, the workshop will emphasize the importance of monitoring immune responses in early phase trials in order to optimize immunological therapies and incorporating pretreatment biomarkers in early phase clinical studies that could predict the effect of specific treatment for patients (predictive biomarkers) in order to identify a population likely to benefit. For more information, visit http://web.ncifcrf.gov/events/cancervaccine/default.asp |
| Author: | FDA and NCI |
| Runtime: | 600 minutes |
| CIT File ID: | 15397 |
| CIT Live ID: | 7907 |
| Permanent link: | http://videocast.nih.gov/launch.asp?15397 |